INTRODUCTION
Despite the ability of combination antiretroviral therapy (cART) to reduce plasma viremia to undetectable levels, treatment does not lead to viral eradication in HIV-infected persons, committing them to lifelong therapy. The inability to eradicate HIV is predominantly due to a reservoir of resting CD4 + T cells non-productively infected by HIV (Bukrinsky et al., 1991; Chun et al., 1997; Finzi et al., 1997; Massanella and Richman, 2016; Siliciano et al., 2003; Soriano-Sarabia et al., 2014) . Resting CD4 + T cells are permissive for HIV entry (Tilton et al., 2014) , but once inside, cytoplasmic host restriction factors such as SAMHD1 can impede the reverse transcription of viral RNA into cDNA (Baldauf et al., 2012; Descours et al., 2012) , leading to abortive infection. The resulting cDNA fragments are sensed by interferon-g (IFN-g)-inducible protein (IFI-16) and induce pyroptosis, leading to the production of pro-inflammatory cytokines and subsequent CD4 + T cell depletion (Doitsh et al., 2010 Monroe et al., 2014) . Although HIV infection of resting CD4 + T cells is mostly abortive (Doitsh et al., 2010; Tilton et al., 2014) , reverse transcription can occasionally be completed and the viral cDNA imported into the nucleus, resulting in either pre-or post-integration latency (Chavez et al., 2015; Pan et al., 2013; Zhou et al., 2005) without an intermediate phase of productive infection (Chavez et al., 2015; Vatakis et al., 2009) . Pre-integration latency occurs when viral cDNA is blocked in the nucleus of a resting cell without being able to integrate into the host chromosome (Petitjean et al., 2007; Pierson et al., 2002; Sloan and Wainberg, 2011) ; subsequent integration can occur after cellular activation, leading to productive infection (Thierry et al., 2015) . Post-integration latency is the most stable form of latency in which viral cDNA is efficiently integrated but leads to no or few viral transcripts (Dahabieh et al., 2015; Hakre et al., 2012; Stevenson, 1997) . These cells contain a viral genome that can be reactivated by different factors, leading to the production of new infectious particles (Bruner et al., 2015; Chun et al., 1997 Chun et al., , 1998 Davey et al., 1999; Ho et al., 2013; Laird et al., 2015; Wong et al., 1997) . Both forms of latency contribute to a reservoir of resting infected cells that are presumed to be invisible to HIV-specific CD8 + T cell responses.
The persistence of this HIV reservoir is a major obstacle to current cure efforts Katlama et al., 2013; Massanella et al., 2013; Pitman et al., 2018; Siliciano and Siliciano, 2013) . Killing HIV-infected resting CD4 + T cells early after viral entry before the reverse transcription step would abrogate both abortive and latent infection and would thus help to decrease CD4 + T cell depletion and inflammation, and could affect the size of the latent viral reservoir. It has been shown that HIV Gag and Pol-specific CD8 + T cell lines recognize peptides from incoming particles after HIV entry into activated CD4 + T cells (Payne et al., 2010 ; Kløverpris et al., 2013) , and at least one study indicates that resting cells may also be targeted (Buckheit et al., 2013) , although the role of antigen processing, restricting human leukocyte antigen (HLA) alleles, and synapse formation in the observed elimination of infected cells was not evaluated. We tested the hypothesis that HIV-specific CD8 + T cells from HIV controllers, a very small proportion of the HIV-infected population who manage to spontaneously control viral replication and maintain stable CD4 + T cell counts without the need for antiretroviral therapy (Carrington and Walker, 2012; Deeks and Walker, 2007; Walker and Yu, 2013) , could recognize and kill non-activated, infected CD4 + T cells due to the recognition of processed viral proteins following viral entry, without requiring productive infection. We used a combination reporter virus system that allowed us to sensitively and specifically track the kinetics of infection of resting CD4 + T cells after viral entry and before any de novo viral protein production. We show that CD8 + T cells from HIV controllers readily establish functional synapses with non-activated infected CD4 + T cells, leading to HLA class I-restricted degranulation, cytokine production, and target cell death, and does not require reverse transcription, indicating that de novo viral protein production is not needed. Moreover, we show that cell-cell transmission also sensitized cells to HIV-specific CD8 + T cell recognition, before viral reverse transcription occurs. This response is significantly more potent in HIV controllers than in progressors, suggesting a mechanism whereby the immune response may influence the size of the HIV reservoir.
RESULTS

HIV Infection of Primary Non-activated CD4 + T Cells
Direct HIV infection of non-activated CD4 + T cells leads predominantly to abortive infection and to a lesser extent, latent infection, which renders cells largely invisible to HIV-specific CD8 + T cells (Pan et al., 2013; Tilton et al., 2014) . Since incoming virions can sensitize activated CD4 + T cells for recognition by CD8 + T cells (Buseyne et al., 2001; Kløverpris et al., 2013; Payne et al., 2010) , we first sought to confirm whether resting CD4 + T cells would likewise be permissive for HIV entry, as previously shown (Tilton et al., 2014) , and to determine whether these cells could be recognized by CD8 + T cells pre-integration and thus before possible abortive infection or establishment of latent infection.
To assess the ability of non-activated CD4 + T cells to become infected with HIV, we used a combination reporter virus system that allowed for discrimination between viral entry into the cytoplasm and subsequent de novo virion production in the infected cell (Tilton et al., 2014) . Resting CD4 + T cells were infected with HIV containing b-lactamase fused to HIV Vpr (Vprblam). Viral entry was detected by pre-labeling cells with a fluorescence resonance energy transfer (FRET) cytoplasmic substrate (coumarin cephalosporin fluorescein, a fluorescent beta-lactamase substrate [CCF2-AM]) composed of a hydroxycoumarin donor conjugated to a fluorescein acceptor via a b-lactam ring. Cleavage of the b-lactam ring is mediated via the b-lactamase protein carried by the incoming virus, inducing an emission shift that allows for the colorimetric detection of viral entry into the cell by flow cytometry. De novo HIV protein production was detected by means of HIV long terminal repeat (LTR)-driven GFP expression Tilton et al., 2014) .
Using this system, we assessed viral entry and levels of productive infection, comparing activated to non-activated CD4 + T cells from healthy donors. The activation status of live CD3 + CD4 + T cells in whole peripheral blood mononuclear cells (PBMCs) was assessed ex vivo by flow cytometry by analyzing the expression of CD25 and CD69, inducible cell surface glycoproteins acquired during lymphocyte activation. In the absence of exogenous stimulation, CD4 + T cells within the PBMCs were quiescent, but were readily activated by incubation with CD3/CD28 beads for 2 days. A representative experiment is shown in Figure S1A . Of note, the activation status was similar when CD4 + T cells were first isolated from PBMCs (data not shown).
Two hours following infection, activated and non-activated CD4 + T cells were assessed for viral entry, as evidenced by b-lactamase-mediated cleavage and fluorescence of the cytoplasmic substrate. Non-activated (CD25 À , CD69
were highly permissive to entry by X4-tropic HIV ( Figure 1A) , with viral entry detected in 65% ± 11% of resting CD4 + T cells at the multiplicity of infection used ( Figure 1B, top) . The entry of R5 tropic viruses was also detected, but to a lesser extent (5% ± 1% of resting CD4 + T cells), consistent with lower C-C chemokine receptor type 5 (CCR5) expression on the resting CD4 + T cells (Figures 1B, bottom, and S1B) . Similar levels of infection were observed when non-activated CD4 + T cells were first isolated from PBMCs (data not shown). To be certain that the cleaved substrate corresponded to viral entry, a virus missing the envelope (HIV DEnv) and a fusion-defective virus (HIV X4 Env-F522Y) were used as controls ( Figure S2 ). Quantification of GFP expression in CD4 + T cells 2 days later revealed that most of the non-activated HIV-exposed CD4 + T cells remained non-productively infected, contrary to activated CD4 + T cells ( Figure 1C ). These results are consistent with previous reports (Haqqani et al., 2015; Tilton et al., 2014) and further suggest that most of the directly infected non-activated CD4 + T cells remain non-productively infected during the period observed.
Recognition of HIV + Non-activated CD4 + T Cells by HIVSpecific CD8 + T Cells We next tested whether an HIV Gag-specific CD8 + T cell line derived by stimulating PBMCs from an HIV controller with a Gag peptide pool could recognize these non-productively infected CD4 + T cells. We first examined the formation of functional immunological synapses by fluorescence microscopy. A cytolytic immunological synapse requires recognition of the viral peptide:major histocompatibility complex (MHC) by the T cell receptor (TCR) and polarization of adhesion molecules including LFA-1 and actin toward the point of contact to form a ring with central clearance, through which cytolytic granules are released (Ritter et al., 2015; Stinchcombe and Griffiths, 2003) . To determine whether immune synapse formation was occurring, HIVinfected non-activated CD4 + T cells (defined by the expression of the b-lactamase cleaved substrate) were co-cultured for 30 min with an autologous HIV Gag-specific CD8 + T cell line 3 h post-HIV entry, a time point shown above to lack viral protein production. Ten contacts between CD4 + T cells and CD8 + T cells from three independent experiments were analyzed by confocal microscopy and are represented with 3D reconstructions (Figure 2A) , showing the presence of perforin (upper images) or the degranulation marker CD107a (lower images) at the point of contact. Quantitative image analysis revealed higher perforin ( Figure 2B ) and CD107a ( Figure 2C ) expression at points of contact with HIV + CD4 + T cells (average 66% ± 3% and 80% ± 6% of points of contact were positive for perforin or granzyme, respectively) compared to non-infected CD4 + T cells (13% ± 3% and 17% ± 3%, respectively). The observed background likely represents random localization of the cytolytic granules near the point of contact. The presence of immune synapses was supported by the observation of an actin ring (blinded counting) for 55% ± 5% of the contacts between HIV + CD4 + T cells and the autologous CD8 + T cells compared to 0% for non-infected CD4 + T cells (Figures 2D and 2E) , and higher actin polarization toward the point of contact ( Figure 2F ) automatically determined by the ratio of actin fluorescence signal at the point of contact versus the rest of the cell with Imaris software. Video S1 shows the rotation of a 3D synapse indicating the polarization and the actin ring at the synapse. Figure 1B ), these results suggest that only a few HIV + CD4 + T cells are required to induce a CD8 + T cell response in this assay, irrespective of co-receptor usage, since we observed only a 2-fold higher CD8 + T cell response with X4 than R5 HIV infection despite a 12-fold higher HIV entry. We further evaluated intracellular expressions of IFN-g, tumor necrosis factor a (TNF-a), and perforin in CD8 + T cells and observed similar polyfunctionality profiles in CD8 + T cells responding to either Gag peptide pool stimulation or to infected, non-activated CD4 + T cells ( Figure S4 ). We conclude that non-productively HIV-infected CD4 + T cells, before viral protein production, elicit similar CD8 + T cell responses to autologous cells loaded with pooled Gag peptides.
The above results suggest that autologous CD8 + T cells can form immunological synapses and degranulate and release cytokines in response to non-productively HIV-infected resting CD4 + T cells. To assess the relation between synapse formation and degranulation, we inhibited the formation of immunological synapses using antibodies against adhesion molecules involved in this interaction (LFA-1, intercellular adhesion molecule 2 [ICAM-2], LFA-3). Consistent with our hypothesis, blocking LFA-I, the main adhesion molecule involved in immunological synapse formation Grakoui et al., 1999) , resulted in decreased degranulation of CD8 + T cells ( Figure 2I ). Blocking LFA-3 or ICAM-2 did not reduce the CD8 + T cell response, suggesting that these molecules may be less important to the recognition of infected, non-activated CD4 + T cells.
CD8 + T Cell Recognition of Non-activated C4 + T Cells following Cell-Cell Transmission
The above results were obtained using cell-free infection with a high viral inoculum. To further confirm our results under more physiologic conditions, we established a cell-to-cell transmission assay to simulate what would be expected to occur in tissues in vivo (Monel et al., 2012; Sourisseau et al., 2007) . HeLa cells were transfected with viral plasmids encoding Vpr-blam viruses: HIV X4, HIV R5, or an X4 virus containing a mutation in the envelope (F522Y) preventing viral fusion with the cellular membrane, but not the interaction with the receptor and co-receptor (Bergeron et al., 1992; Clavel et al., 1989) . HeLa cells were subsequently co-cultured with non-activated, CCF2-AM labeled uninfected CD4 + T cells for 2 h. A Vpr-blam assay was performed on an aliquot of the CD4 + T cells, confirming cell-to-cell transmission and viral entry. The remaining CD4 + T cells were co-cultured with primary autologous bulk CD8 + T cells for 5 h in the presence of CD107a antibody to analyze CD8 + T cell degranulation ( Figure 3A ). In this system, primary, non-activated CD4 + T cells were permissive to HIV X4 and HIV R5 entry by cell-to-cell transmission from transfected HeLa cells, but were not infected by the fusiondefective virus F522Y ( Figure 3B ). Furthermore, viral entry into resting CD4 + T cells in this assay induced CD8 + T cell degranulation directly ex vivo using unstimulated PBMCs from HIV-infected donors ( Figure 3C ). The relatively low levels of specific degranulation are consistent with expectations, given the frequency of HIV-specific effector CD8 + T cells in PBMCs (data not shown). These data confirm the previous observations of CD8 + T cell recognition of non-productively (Kløverpris et al., 2013; Payne et al., 2010; Buseyne et al., 2001) . We next investigated whether this was also the case for non-activated HIV + CD4 + T cells in which activities of antigen-processing enzymes are lower than in activated CD4 + T cells (J.B., unpublished data). To address this question, cells were infected with a wild-type (WT) HIV X4 virus, a fusion-defective mutant (HIV F522Y), or a virus rendered non-infectious by the lack of the envelope protein (HIV DEnv), and the experiment was conducted in the presence or absence of the reverse transcriptase inhibitor efavirenz. As shown in Figure 4A , degranulation in response to fusion-defective virus was reduced to background levels. Thus, virus entry into the cytoplasm, and not potential stress signaling caused by Env-receptor and co-receptor interactions, was absolutely necessary to induce an HIV-specific CD8 + T cell response.
We also determined that viral reverse transcription was not required to trigger the CD8 + T cell degranulation, as shown by the same level of CD107 + CD8 + T cells with or without efavirenz ( Figure 4A ). Based on these data, we hypothesized that CD8 + T cell responses are triggered shortly after viral entry into the cytoplasm of the target cell, suggesting a role for incoming, as opposed to de novo transcribed, viral particles. Anti-HLA class I antibody blockade during the following 5-h incubation period post-infection resulted in a marked decrease in CD8 + T cell responses (Figure 4B) , indicating that the CD8 + T cell degranulation observed in response to HIV + non-activated CD4 + T cells is driven by HLA class I presentation of viral peptides entering the cytoplasm after viral fusion. To more precisely define the involvement of antigen processing in the recognition of non-activated cells, we blocked enzymatic aminopeptidase activities with bestatin, cysteine cathepsin activities with E64, and the proteasome with epoxomicin (Bogyo and Wang, 2002; Groll and Huber, 2004; Mathé , 1991; Vaithilingam et al., 2013) . Inhibition of aminopeptidases with bestatin or blocking of proteasome activities, but not blocking of cysteine cathepsin activities, resulted in a decrease in CD8 + T cell responses to HIV + non-activated CD4 + T cells ( Figures   4C-4E ). The results from these pharmacological inhibition exper- iments support that antigen processing is a prerequisite for CD8 + T cell recognition of non-productively infected CD4 + T cells.
These data suggest that HIV fusion into the cytoplasm, HIV degradation by aminopeptidases and proteasomes, but not reverse transcription, are required for antigen processing of incoming viral particles and presentation by HLA class I ( Figure 4F ).
Killing of HIV
+ Non-activated CD4 + T Cells by HIVSpecific CD8 + T Cells The above studies show that HIV-infected, non-activated CD4 + T cells trigger CD107a expression, but do not directly demonstrate that these cells are killed. To address this, we performed a chromium release assay using HIV + non-activated CD4 + T cells (Chen et al., 2012) shortly after viral entry ( Figure 5A ). Release of 51 Cr into the supernatant was quantified, revealing direct killing by autologous HIV-specific CD8 + T cell lines at multiple effector-to-target ratios ( Figures 5B and 5C ). Furthermore, killing was dramatically decreased in the presence of an anti-HLA-I antibody compared to isotype antibody controls ( Figure 5B ) and in the presence of anti-LFA1 antibody, confirming the requirement for functional immunological synapses for efficient killing ( Figure 5C ). We conclude that HIV-specific CD8 + T cells are able to not only degranulate upon recognition of HIV + non-activated CD4 + T cells within hours of viral fusion but also kill these cells. Figure 6A ), IFN-g production (p = 0.007; Figure 6B ), and macrophage inflammatory protein 1b (MIP-1b) production (p = 0.016; Figure 6C ). Of note, there were no differences in the production of TNF-a ( Figure 6D) , perforin, or granzyme B ( Figures S5A and S5B ) by the Gag-specific CD8 + cells from HIV controllers and HIV progressors. As HIV particles are mainly composed of Gag and Pol proteins, we hypothesized that viral peptides presented through HLA-I shortly after HIV entry would preferentially target these proteins. target cell ratios for 6 h. Blocking antibodies against HLA-I or LFA-I were added before co-culture, as indicated. The release of 51 Cr in the supernatant was measured, and the percentage of specific killing was calculated as [(mean experimental cpm À mean spontaneous cpm)/(mean maximum cpm À mean spontaneous cpm)] 3 100. Means ± SDs for two independent experiments in duplicate with cells coming from two different HIV controllers are represented, and statistics were calculated with a two-way ANOVA multiple comparison test relative to 1:10 isotype condition. **p < 0.01 and ***p < 0.001.
We therefore tested whether the greater levels of recognition of non-productively infected cells in HIV controllers versus progressors (Figure 6A ) were attributable to greater frequencies of HIV-Gag-specific CD8 + T cells. Most of the HIV progressor patients (9/10) showed CD8 + T cell responses to Gag peptide pool stimulation (final concentration of 1 mg/mL/peptide), as represented in Figure 6E (top), which was not significantly different from that of HIV controllers ( Figure S5D ). Following normalization of the IFN-g response to non-productively infected cells to the total magnitude of Gag-specific CD8 + T cell response in the same subjects, we still observed proportionally greater responses in HIV controllers as compared to progressors (50% ±12% versus 18% ± 5.4%, p = 0.0334; Figure 6F ). Of note, expression of programmed cell death protein 1 (PD-1), an exhaustion marker, was comparable in both groups ( Figure S5C ), and exhaustion blockade did not enhance cell killing ( Figure S6) . Thus, the increased responsiveness of CD8 + T cells from controllers to non-productively infected cells cannot be attributed to greater magnitude or differential exhaustion status of Gag-specific CD8 + T cell responses.
To further analyze the role of the CD8 + T cell response in HIV control, we evaluated whether there was a link between IFN-g production by CD8
+ T cells and the size of the reservoir in these patients, measured by digital droplet PCR ex vivo, as described by Henrich et al. (2012) . Persons for whom HIV DNA could be measured were included (n = 6 for HIV progressors and n = 7 for HIV controllers). We observed a significant Spearman inverse correlation between the antiviral response and the size of the reservoir for all patients ( Figure 6G , left), but also when only the HIV controllers were analyzed (Figure 6 G, right) . Moreover, CD8 + T cells from HIV progressors did not respond to HIVinfected, non-activated CD4 + T cells, even with a blockade of exhaustion ( Figure S6 ), which is consistent with a role for HIVspecific CD8 + T cells in containing the HIV reservoir in non-activated CD4 + T cells.
DISCUSSION
HIV reservoirs represent a major barrier to HIV eradication (Archin et al., Kimata et al., 2016) , and substantial research efforts are being directed toward the goal of identifying and eliminating this obstacle to cure Pitman et al., 2018) . Latently infected resting CD4 + T cells represent the majority of the HIV reservoir (Bruner et al., 2015; Siliciano and Siliciano, 2015) , and it has been shown that HIV latency can be established in resting CD4 + T cells directly after infection, without intervening productive infection (Chavez et al., 2015) . Therapeutic strategies aimed at eliminating HIV reservoirs have been dominated by the ''kick and kill'' paradigm, which involves reactivating latent CD4 + T cells to induce de novo production of viral proteins, and the subsequent elimination by the immune system, notably CD8 + T cells Pegu et al., 2015) . Another strategy could be the elimination of infected cells before the establishment of the reservoir. Here, we show that ex vivo CD8 + T cells from HIV controllers (possessing at least one HLA-B*27 or HLA-B*57 allele), but not HIV progressors expressing the same alleles, are able to directly recognize and kill HIV-infected non-activated CD4 + T cells through the formation of immunologic synapses and class I restricted recognition of processed viral peptides. This occurs within a few hours following viral entry, allowing an antiviral response before HIV reverse transcription and thus before the eventual establishment of HIV latency. Moreover, this recognition precedes the production of the incomplete reverse transcripts that are needed to induce pyroptosis and the release of inflammatory molecules (Doitsh et al., 2010 . These data indicate that HIV-specific CD8 + T cell responses have the potential to reduce the establishment of an HIV reservoir in non-activated CD4 + T cells and reduce HIV-induced inflammation, hence contributing to HIV control. To further define the mechanism of recognition, we show that the recognition of non-productively infected resting CD4 + T cells by HIV-specific CD8 + T cells occurs through synapse formation and requires the presentation of viral peptides derived from incoming viral particles on HLA-I molecules. Moreover, we show that non-activated cells can be targeted either following exogenous infection or cell-to-cell spread, which is likely a major mode of ongoing viral replication in vivo (Chen et al., 2007; Dimitrov et al., 1993; Phillips, 1994) . Our results indicate that incoming viral proteins are degraded in the cytosol of non-activated cells by the proteasome and the aminopeptidases to produce antigenic peptides for presentation by HLA class I, as blocking these enzymes or HLA class I reduced the CD8 + T cell responses.
It is important to note that these results were obtained using PBMCs from HIV controllers expressing HLA-B*27 or HLA-B*57 and with the laboratory strain of HIV NL4.3 possessing a wild-type sequence for most of the optimal epitopes. Further studies will be required to examine the recognition of non-activated infected cells in the context of other restricting HLA-I alleles. However, our results provide support for the hypothesis that proteins from incoming particles are degraded in the cytosol and presented directly at the surface of the target cell through HLA class I. Previous studies have reported pre-integration presentation of the SIV-Gag peptides (Sacha et al., 2007) and the HIV-Gag KRWIILGLNK epitope on HLA-B*27 in activated CD4 + T cells (Buseyne et al., 2001; Kløverpris et al., 2013) . In addition, a previous study (Buckheit et al., 2013) efficiently present antigen from incoming particles. Therefore, our study confirms that resting CD4 + T cells are able to present antigens from incoming particles through HLA-I and provides some mechanistic insight regarding this antigen-presentation pathway.
Additional studies will be required to understand why CD8 + T cells from HIV controllers are more efficient in recognizing non-activated infected cells and to determine factors that modulate this recognition. It will be important also to determine whether this is unique to the protective alleles HLA-B*27 and B*57 or can be seen in the context of other alleles. Nevertheless, these data indicate that non-productively infected cells can be targeted by CD8 + T cells, suggesting a path forward to reducing the viral reservoir. Furthermore, our study could have implications for T cell-based prophylactic vaccines as an adjunct to antibody-mediated vaccines, as the presence of these cells at the time of infection may limit the establishment of the reservoir.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Study subjects PBMC from HIV-1-infected individuals were used for this study according to protocols approved by the Institutional Review Board of the Massachusetts General Hospital. Peripheral blood mononuclear cells (PBMC) were isolated using Ficoll-Hypaque density gradient centrifugation HIV Controllers include Elite Controllers who were defined as having HIV-1 RNA below the level of detection for the respective available ultrasensitive assay (e.g., < 75 RNA copies/ml by cDNA or < 50 copies by ultrasensitive PCR) without antiretroviral therapy and Viremic Controllers as having HIV-1 RNA between 50 and 2000 RNA copies/mL. CD4+ T cell counts, viral loads and HLA types were determined as described (Pereyra et al., 2008) . HIV Progressors were treated with Anti-retroviral (ARV) therapy for 1 to 4 years. Characteristics of the study subjects are shown in Table 1 .
Cell lines
HeLa cells and HEK293T cells (both from ATCC) were cultured at 37 C in Dulbecco Modified Eagle Medium (DMEM) supplemented with 10% of Fetal Bovine Serum and 1% of penicillin/streptomycin.
METHOD DETAILS
Proviral DNA constructs HIV proviral constructs coding for replicative NL4.3-GFP-X4 and NL4.3-GFP-R5 were previously described (Murooka et al., 2012) and were kindly provided by Thomas Murooka and Thorsten Mempel. Env-deleted (HIVDEnv) and fusion-defective (HIV F522Y) HIV mutants were previously described (Bergeron et al., 1992; Clavel et al., 1989) . F522Y carries a point mutation in Env, which abrogates fusion but retains CD4 binding ability.
non-activated CD4+ T cells were added to the transfected and washed HeLa cells for 2 hours. The non-activated CD4+ T cells were then harvested, washed, and processed as described above for the cell-free virus assay. Target cells were gated based on their sizes to exclude doublets and syncytia.
Generation of HIV-specific CD8+ T cell lines CTL lines specific were generated by stimulation with designated single peptides or a Gag peptide pool using cryopreserved PBMC from HLA-B*27 or B*57 HIV Controllers. PBMC were thawed and incubated with the designated peptide (final concentration 1ug/mL/peptide) for 10 days in R10 medium (RPMI supplemented with 10% fetal bovine serum plus HEPES buffer, penicillin, streptomycin, and L-glutamine). IL-2 (50 U/mL) was added on day 3. Specificity for cognate peptide was tested on day 10 by intracellular cytokine staining (ICS) for IFN-g.
Confocal Microscopy and Analysis
Non-activated CD4+ T cells negatively isolated from PBMC were infected for 2 hours with HIV-X4 Vpr-blam viruses. After infection, the cells were washed and incubated at 37 C. Two hours later the cells were loaded with the CCF2-AM loading kit for 1 hour at room temperature. During this time, autologous Gag pool-stimulated CD8+ T cell lines were incubated with 5M CellTracker TM Orange CMTMR dye according to the manufacturer's instructions. CD4+ T cells and CD8+ T cells were then mixed together at a 1:1 ratio and were loaded onto polylysine-coated coverslips (1x10 6 cells in 160uL) in 24 well plates. After 30 min at 37 C, cells were fixed with paraformaldehyde (PFA) 4% for 15min at room temperature, permeabilized with Triton 0.5% for 15min at room temperature, blocked with PBS containing 3% bovine serum albumin (BSA) for 1 hour at room temperature and stained with AlexaFluorâ 488 Phalloidin (Molecular Probes) and AlexaFluorâ 647 anti-CD107a (clone H4A3 Biolegend #328612) or AlexaFluorâ 647 anti-perforin (clone dG9 Biolegend #308109) overnight at 4 C. The coverslips were then mounted on slides using ProLong Gold Antifade Reagent (Life Technology). Images were acquired with a Zeiss LSM 510 confocal microscope equipped with argon (488nm) and Diode (405nm, 561nm) lasers, 100X oil immersion objective and ZEN software. At least 10 contacts between CD4+ T cells and CD8+ T cells were analyzed per condition with Z stacks spaced by 0.33 mm. The 3D images were then reconstituted using the IMARIS software (Bitplane) and surfaces were created for each channel after background deduction. Quantification of synaptic actin polarization 3D reconstituted images of synapses were analyzed with Imaris software. The fluorescent signal of the Phalloidin was quantified at the site of contact between the effector and the target cell and compared to the Phalloidin signal on the rest of the CD8+ T cell with Imaris software. Approximately 30 cells were analyzed per condition and the mean of the ratios (actin at point of contacts/actin in rest of CD8+ T cell) was calculated. Actin ring quantification 3D reconstituted images of synapses between HIV+ non-activated CD4+ T cells and CD8+ T cells were analyzed with Imaris software. Surfaces were created for each channel after background deduction. En face views from each duplex were taken and the blue pixels (target cells) were removed to allow an unobstructed view of the actin stain at the interface. The percentage of cells showing a surface corresponding to actin in a ring-shape was blindly determined for each experiment. Perforin and CD107a quantification at the site of contact 3D reconstituted images of synapses were analyzed with Imaris software. A 3D rectangle was drawn to delimit the interface between the two cells. Spots objects identifying point-like objects were automatically created using the ''Spots'' tool of the Imaris software for the channel corresponding to CD107a or perforin staining after background deduction. The percentage of interfaces presenting perforin or CD107a spots was determined for each experiment.
Flow cytometry analysis
Non-activated PBMC were infected or not with the indicated HIV strains for 2 hours at 37 C. Free virions were then washed with PBS. The cells were resuspended in fresh media and incubated 5 hours at 37 C in the presence of PE/CY7 anti-CD107a antibody (clone H4A3 Biolegend #328617) and in the presence of GolgiStop TM (BD Biosciences #554724) and GolgiPlug TM (BD Biosciences #555029) for intracellular cytokine staining. The cells were then harvested and stained for viability (Fixable blue viability dye, Life Technologies #L-23105) for 30 min, then stained with PE-CD3 (clone HIT3a Biolegend #300307), V500-CD8 (clone RPA-T8 BD horizon #560775) and BV605-CD4 (clone OKT4 Biolegend #317437). After fixation and permeabilization (BD Cytofix/ Cytoperm TM #554722) the cells were stained for Pacific blue-Perforin (clone B-D48 Biolegend #353305), APC-IFN-g (clone B27
Biolegend #506510), FITC-TNF-a (clone MAb11 BD PharMingen #554512), PerCP-Cy5.5-MIP1-b (clone D21-13551 RUO BD PharMingen #560688) and AlexaFluor â 700-GranzymeB (clone GB11 BD PharMingen #561016). Fluorescence signals were then quantified using a BD LSR-II flow cytometry system (Becton Dickinson) with FACSDiva8 software and results were analyzed with FlowJo software.
Blocking antibodies and drugs
For blockade of adhesion molecules, purified anti-human CD11a antibody (Genetex â cat: GTX26132 clone: 38), anti-human CD18
antibody (Biolegend â cat: 366302 clone CBR LFA-1/2), anti-human ICAM-2 antibody (Genetex â cat: GTX42521 clone: CBRIC2/2) and anti-human LFA3 antibody (Biolegend â cat: 330912 clone: TS2/9) were used.
For blockade of the HLA class I molecule, Ultra-LEAF TM purified anti-human HLA-A, B, C antibody (BioLegend â clone W6/32) was used. In order to block HIV reverse transcription, the retroviral drug Efavirenz (Sigma; SML0536) was used at a final concentration of 100nM. For the study of antigen processing pathways, the proteasome hydrolytic activities were blocked with epoxomicin (Enzo Life sciences-BML-PI127-0100), the aminopeptidase activities with Bestatin (Sigma-Aldrich B8385) and the cysteine proteases (cathepsins B, H and L) with E64 (Enzo Life Sciences ALX-260-007) at different final concentrations as indicated on the figures.
HIV cell-to-cell transmission HIV cell-to-cell transmission was performed as previously described (Monel et al., 2012) . Donor HeLa cells were transfected with different proviral constructs (HIV X4, HIV R5, HIV F522Y) and plated in 24-well plates (10 5 cells per well). Cells were then washed to eliminate cell-free virions 48 h post-transfection, and 5x10 5 target cells (non-activated CD4+ T cells) were added in a final volume of 500 ml. Target cells were collected 2 hours later; an aliquot was used for a Vpr-blam assay to check HIV entry while remaining cells were co-cultured (ratio 1:1) with autologous CD8+ T cells in 24-well plates for 5 hours in the presence of anti-CD107a antibody. Live CD8+ T cells were then analyzed by flow cytometry for degranulation.
Chromium release assay
Primary non-activated CD4+ T cells were isolated from PBMC by negative selection (EasySep TM Human CD4+ T cell enrichment kit from StemCell) and infected with 500ng of p24 (determined by ELISA) of NL4.3 containing the fusion protein Vpr-blam for 2 hours at 37 C. After infection, the cells were washed, and an aliquot was removed to perform an HIV fusion assay as described ahead. The remaining cells were labeled with chromium (around 50 mCi) for 1 hr at 37 C. HIV Gag pool-or Gag-KK10-stimulated CD8+ T cell lines were then added at the indicated effector-target ratios, and a standard 6 hour chromium release assay was performed as previously described (Yang et al., 2003) . The plates were spin down to pellet the cells and the supernatants were transferred from each well to the well of an absorbent plate. The plates were dried overnight and put in a plate reader to measure the 51 Cr release. Each sample were performed at least in duplicate. Percent specific lysis was calculated as [(mean experimental cpm -mean spontaneous cpm)/ (mean maximum cpm -mean spontaneous cpm)] 3 100. Spontaneous and maximum releases were determined by incubating the labeled target cells with medium alone or 5% Triton X-100, respectively.
Quantification of HIV DNA reservoir by digital droplet PCR Digital droplet PCR was performed as previously described (Henrich et al., 2012) . Genomic DNA was extracted from primary non-activated CD4+ T cells using the Gentra Puregene kit (Gentra) following the manufacturer's instructions. For each PCR reaction, 5 units of restriction enzyme BsaJI (NEB) was directly mixed with 300ng of DNA, ddPCR Supermix for Probes (Bio-Rad), and final concentrations of 900nM primers and 250nM probe. Primers/Probes were: RPP30 -forward primer GATTTGGACCTGCGAGCG, reverse primer GCGGCTGTCTCCACAAGT, probe VIC-CTGAACTGAAGGCTCT-MGBNFQ; HIV-gag -forward primer TACTGAC GCTCTCGCACC, reverse primer TCTCGACGCAGGACTCG, probe FAM-CTCTCTCCTTCTAGCCTC-MGBNFQ. Droplets were prepared using the QX100 Droplet Generator (Bio-Rad) following the manufacturer's instructions. Sealed plates were cycled using the following program: 95 C for 10 min; 40 cycles of 94 C for 30 s, 60 C for 1 min; and 98 C for 10 min, with 2 C/sec ramping speed to ensure even droplet heating. Reactions were analyzed using the QX100 Droplet Reader and number of template molecule per ml of starting material was estimated using the Quantalife ddPCR software. We aimed to run 8 replicates of ddPCR per sample -depending on the amount of DNA availability. We consistently applied a pre-determined exclusion criterion to outliers that deviated from mean values by > 2x the standard deviation.
QUANTIFICATION AND STATISTICAL ANALYSIS
Most of the data are represented as Mean ± standard deviation and statistical analyses were performed using GraphPad PRISM software. t tests were used to compare two groups of samples, one-way ANOVA multiple comparison tests were used to compare each column to a control column or to every other columns and two-way ANOVA multiple comparison tests were used when grouped data were analyzed and compare to a control column ( Figures 5B and 5C ). Regarding Figure 6G we used a Spearman correlation to assess monotonic relationships between the Log 10 of Gag copies/10^6 non-activated CD4+ T cells and the CD8+ T cell IFN-g response. The Spearman's rank correlation coefficient (r s ) is indicated in the Figure. The corresponding tests are indicated for each figure in the legend. In Figure 6 , the n indicated in the legend represents the number of patients studied for each group (n = 10 Controllers and n = 10 Progressors for Figures 6A-D and 6F; n = 12 for Figure 6 left panel; n = 6 Controllers and n = 6 Progressors for Figure 6G right panel. No methods were used to determine whether the data met assumptions of the statistical approach.
